Take a look at these MSK-authored articles, recently published and tweeted over 240 times thus far:

• Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature. 2017 Nov 23;551(7681):512-516. DOI: 10.1038/nature24462
• FDA approval of tisagenlecleucel: Promise and complexities of a $475 000 cancer drug. JAMA. 2017 Nov 21;318(19):1861-1862. DOI: 10.1001/jama.2017.15218
• Clinically meaningful benefit: Real world use compared against the American and European guidelines. Blood Cancer J. 2017 Dec 14;7(12):645. DOI: 10.1038/s41408-017-0009-8

To read the tweets, click on the Altmetric donut from the links above and go to “Twitter.” See all MSK publications added to Synapse in January 2018.